Real-time enrollment status for this b-cell mediated autoimmune disorders clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 10:25 AM UTC
| NCT Number | NCT06680037 |
| Recruiting Status | Recruiting |
| Condition | B-cell Mediated Autoimmune Disorders |
| Phase | PHASE1 |
| Target Enrollment | 100 participants |
| Active Locations | 8 sites in the US |
| Sponsor | TG Therapeutics, Inc. |
| Last Updated on CT.gov | July 20, 2026 (Jul 20, 2026) |
As of August 27, 2026: Clinical trial NCT06680037 is currently recruiting participants. This phase1 study for b-cell mediated autoimmune disorders is actively seeking new participants at 8 locations across the United States. The study is sponsored by TG Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06680037 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06680037 was last updated Jul 20, 2026 (July 20, 2026). HelloStudys verifies this status automatically.